How Long Can You Live Once Ascites Starts?

Survival after ascites develops ranges from weeks to years, depending almost entirely on the underlying cause and how well it responds to treatment. When cirrhosis is the driver, which accounts for the vast majority of cases, roughly half of patients with uncomplicated ascites are still alive at two years, but that number drops sharply if the fluid stops responding to medications or if serious complications set in. When cancer is the cause, median survival is measured in months. Those wide ranges reflect how many variables are in play, from liver function and kidney health to muscle mass, sodium levels, and whether the person is still drinking alcohol.

Why Ascites Is a Turning Point in Liver Disease

Ascites is a buildup of fluid in the abdominal cavity. In liver disease, it marks the transition from “compensated” cirrhosis, where the liver is scarred but still managing, to “decompensated” cirrhosis, where the liver is failing to keep up with the body’s demands. The fluid accumulates because of a chain reaction: scarring raises pressure in the portal vein (the major vessel feeding the liver), which triggers blood vessels in the gut to widen, which in turn causes the kidneys to hold onto salt and water aggressively.¹ The result is fluid leaking out of blood vessels and pooling in the abdomen. Hormonal signals compound the problem, locking the body into a cycle of fluid retention that gets harder to break as liver function worsens.²

This transition matters for prognosis because it signals that the liver’s reserve is largely exhausted. Before ascites appears, people with cirrhosis can live for a decade or more. Once ascites develops, the clock speeds up considerably. How fast depends on the factors discussed below.

Ascites That Responds to Treatment

Most people who develop ascites from cirrhosis initially respond to a combination of salt restriction and diuretics. Spironolactone, which blocks a hormone that drives sodium retention, is usually the first drug tried and works in the majority of patients who don’t have severe kidney problems. When it isn’t enough on its own, a loop diuretic like furosemide is added.³ Salt restriction helps the diuretics work more efficiently, and one randomized trial found that patients on a low-sodium diet cleared their ascites faster, though long-term survival differences between restricted and unrestricted diets were modest.⁴

When diuretics control the fluid effectively and no other major complications are present, survival extends well beyond what most people expect from the phrase “liver failure.” Many of these patients live several years, especially if the underlying cause of cirrhosis can be treated, such as stopping alcohol use or suppressing hepatitis B.

Refractory Ascites and the Drop in Survival

About one in ten patients with cirrhotic ascites eventually reaches a point where diuretics no longer work or cause side effects too severe to tolerate, like dangerous drops in sodium or kidney damage. This is called refractory ascites. Survival drops markedly at this stage, with roughly a 50% chance of being alive at one year.⁵ These patients face a cascade of complications including malnutrition, abdominal hernias, and infections, each of which carries its own mortality risk.⁶

At this point, doctors usually recommend evaluating the patient for liver transplantation, since the trajectory without one is grim.⁷ In the meantime, management shifts to repeated large-volume paracentesis, where a needle is inserted into the abdomen to drain liters of fluid at a time, usually with an infusion of albumin to prevent circulatory problems afterward. A meta-analysis of randomized trials found that giving albumin during these procedures reduced complications and lowered mortality compared to other fluid replacements.⁸

How TIPS Changes the Outlook

For patients with refractory ascites who aren’t candidates for immediate transplant, a procedure called TIPS (transjugular intrahepatic portosystemic shunt) can make a substantial difference. TIPS is a small metal stent placed inside the liver that reroutes blood flow to relieve portal pressure. A multicenter study found that one-year survival was about 78% in patients who received TIPS, compared with roughly 47% in those managed with repeated paracentesis.⁹ A meta-analysis confirmed the survival benefit, showing that TIPS also reduced the chances of developing hepatorenal syndrome and needing further paracentesis.¹⁰

The trade-off is a higher rate of hepatic encephalopathy, a condition where toxins the liver normally clears build up and affect brain function, causing confusion or drowsiness. In one study, about a quarter of TIPS patients developed this complication, compared with around 6% of those getting paracentesis alone.⁹ That risk is manageable for many people with medications like lactulose and rifaximin, but it makes TIPS unsuitable for patients who already have severe encephalopathy or very advanced liver failure.

When Infection Strikes the Fluid

One of the most feared complications of ascites is spontaneous bacterial peritonitis (SBP), an infection of the ascitic fluid that develops without any obvious source like a ruptured organ. It occurs because bacteria migrate through the gut wall, which becomes more permeable as liver disease worsens. A large analysis found that about one in ten patients with SBP dies within 30 days. By one year, roughly 44% have died, and by three years the figure climbs to about 61%.¹¹

Those numbers get considerably worse when SBP occurs alongside sepsis or liver cancer. Patients who had both SBP and hepatocellular carcinoma had a 30-day mortality above 50%, compared with about 23% in those with SBP but no cancer.¹² Even among SBP survivors, the episode is a clear signal that the liver is deteriorating. One older study found that among transplant-eligible patients with moderate liver disease who survived their first SBP episode, one-year survival was around 80%, but for those with more severe disease it dropped to about 26%.¹³ This is why an episode of SBP typically fast-tracks a transplant evaluation.

Hepatorenal Syndrome

The kidneys sit in the crossfire of advanced liver disease. As cirrhosis progresses, the profound circulatory changes that cause ascites also starve the kidneys of blood flow, and they begin to shut down. This process, when it escalates rapidly, is called hepatorenal syndrome type 1, and it carries one of the shortest survival timelines of any cirrhosis complication. A survey of clinical practice found that three-month survival for type 1 was under 20%, and patients who had two or more negative prognostic markers (like rising creatinine or high bilirubin) had a 97% mortality rate.¹⁴ Among patients with ascites who don’t yet have hepatorenal syndrome, the probability of eventually developing it is about 18% within the first year and 39% by five years.¹⁵

Survival improves for those who respond to treatment with vasoconstrictors and albumin, but the response rate is far from universal. Hepatorenal syndrome is among the strongest indications for urgent liver transplantation, since the kidneys often recover once a healthy liver restores normal circulation.

What Predicts How Long Someone Has

Doctors don’t just eyeball ascites and guess. They rely on scoring systems that weigh multiple lab values and clinical features. Two of the most widely used are the Child-Pugh score, which factors in albumin, bilirubin, clotting time, ascites severity, and encephalopathy, and the MELD score, which uses bilirubin, creatinine, and clotting time.¹⁶ A modified version, MELD-Na, adds serum sodium to the equation and has shown better accuracy in predicting one-year mortality, especially in patients with ascites.¹⁷

Sodium deserves special attention. Low sodium in the blood (hyponatremia) is a marker of how hard the body is working to compensate for failing circulation, and it independently predicts death. In patients with ascites and low MELD scores, where the standard score might underestimate risk, serum sodium provided better prognostic accuracy than the MELD alone.¹⁸ Among patients experiencing an acute flare-up on top of chronic liver failure, hyponatremia nearly doubled the risk of dying within 90 days, and when combined with organ failure, the three-month transplant-free survival was only about 36%.¹⁹

Another underappreciated sign is dilutional hyponatremia that develops without an obvious trigger like diarrhea or overuse of diuretics. A study found that patients whose sodium dropped spontaneously, without any identifiable cause, had a strikingly high mortality rate compared to those whose low sodium had a correctable trigger.²⁰

Cancer-Related Ascites

Ascites caused by cancer rather than cirrhosis follows a different and generally bleaker trajectory. Overall, the average survival from the time malignant ascites is diagnosed is about 20 weeks.²¹ A retrospective study put the median at about 5.7 months, though the range was wide. Patients with ovarian cancer survived longer than those with gastrointestinal cancers or cancers of unknown origin. Low albumin, low total protein, and the presence of liver metastases were each independently linked to shorter survival.²²

Pancreatic cancer with ascites is among the worst scenarios. One study of metastatic pancreatic cancer patients found a median survival after ascites diagnosis of just 27 days. Patients who continued chemotherapy after ascites developed lived a median of about two months, while those receiving only supportive care had a median of about 16 days.²³ Another study of pancreatic ductal adenocarcinoma found that patients with ascites had a median survival of about 10 months, compared to about 15 months for those without ascites, though this included patients across all stages, not just metastatic disease.²⁴

Whether chemotherapy continues after ascites develops makes a substantial difference for some cancer types but depends heavily on the patient’s overall condition and performance status. For many, the focus shifts to comfort.

When Ascites Comes From the Heart

Liver cirrhosis and cancer dominate the conversation, but heart failure is another cause. When the heart can’t pump blood efficiently, pressure backs up into the liver’s veins and fluid weeps into the abdomen. Sometimes this chronic congestion even causes a secondary form of cirrhosis called cardiac cirrhosis. The prognosis in these cases depends mostly on the underlying heart disease rather than the liver itself, and managing the heart condition is the primary goal.²⁵ If the cardiac problem can be treated effectively, whether through medications, valve repair, or other interventions, the ascites can resolve or stabilize, and survival can be considerably longer than in cirrhotic or malignant ascites.

Muscle Loss and Its Surprising Role

One factor that doesn’t get enough attention is sarcopenia, the loss of skeletal muscle mass. Cirrhosis is a catabolic disease: the failing liver struggles to process nutrients, and patients often lose muscle even if they appear to have a normal or elevated body weight (the ascites fluid can mask how much lean tissue has wasted away). A multicenter study in China found that cirrhotic patients with sarcopenia had roughly triple the mortality of those without it and also developed ascites at a higher rate.²⁶ Research specifically in patients who already had ascites found that those with significant muscle wasting had more than five times the death risk of those who maintained muscle mass.²⁷

Sarcopenia also appears to predict who will develop ascites in the first place. Among compensated cirrhotic patients, those with sarcopenia were about twice as likely to develop ascites as a first decompensating event, independent of how severe their portal hypertension was.²⁸ Adequate protein intake and supervised exercise, to the extent they’re tolerated, are increasingly recognized as meaningful interventions, not just nice-to-haves.

Alcohol Abstinence as a Survival Factor

For the large proportion of ascites cases driven by alcohol-related liver disease, quitting alcohol has an outsized effect on survival. A study tracking patients across all stages of portal hypertension found that abstinence cut the risk of further decompensation by about 60% and halved the risk of liver-related death.²⁹ Even among patients who already had moderate ascites, abstinence raised the proportion who could be managed with diuretics alone from about 53% to 76%.³⁰ In the realm of cirrhosis management, few interventions show this strong an effect. A separate study confirmed that abstinence remained an important predictor of survival even in decompensated disease.³¹

Liver Transplant and What Happens After

Liver transplantation is the only treatment that truly reverses the process causing cirrhotic ascites. Survival rates after transplant are generally excellent compared to the alternatives, with one-year survival over 90% in many centers. Persistent ascites after transplant is uncommon, occurring in about 5-6% of cases, and is most often caused by infection rather than a return of the underlying liver disease. Treatment resolved the fluid in about three-quarters of those cases, though patients with persistent post-transplant ascites had lower one-year survival (about 76%) than those without it (about 92%).³²

The challenge is access. Donor organs are scarce, waiting lists are long, and not everyone qualifies. Active alcohol use, certain cancers, severe infections, and significant extrahepatic disease can all disqualify candidates. For patients who do qualify, transplant referral should happen early, ideally at the first sign that ascites is becoming difficult to control.

Palliative Drainage When Cure Is Not the Goal

For patients with malignant ascites or end-stage cirrhosis who are not transplant candidates, comfort becomes the priority. Repeated trips to the hospital for paracentesis are burdensome, and tunneled peritoneal drainage catheters offer an alternative. These are semi-permanent tubes placed through the abdominal wall that allow fluid to be drained at home, on the patient’s schedule.³³ Studies have consistently found them safe and effective in both malignant and non-malignant ascites, with high patient satisfaction and relatively low complication rates.³⁴

These catheters don’t extend life, but they reduce the bloating, shortness of breath, and immobility that make advanced ascites so miserable. For many patients and families, quality of the remaining time matters as much as its length, and having control over symptom management at home can be a meaningful shift in how that time feels.